Mucoepidermoid carcinoma of the lung, response to EGFR inhibitors, EGFR and K-RAS mutations, and differential diagnosis

Giulio Rossi; Giuliana Sartori; Alberto Cavazza; Stefano Tamberi

doi:10.1016/j.lungcan.2008.09.007

Mucoepidermoid carcinoma of the lung, response to EGFR inhibitors, EGFR and K-RAS mutations, and differential diagnosis

Giulio Rossi, Giuliana Sartori, Alberto Cavazza, Stefano Tamberi

Arcispedale Santa Maria Nuova

Research output: Contribution to journal › Article › peer-review

Abstract

Mucoepidermoid carcinoma (MEC) of the lung needs to be carefully distinguished from other lung tumors with similar features, particularly from adenosquamous carcinoma, this latter tumor frequently showing EGFR mutations. In contrast with the data reported by Han et al in the last July issue of Lung Cancer, neither EGFR nor K-RAS mutations were observed in MEC from caucasian patients.

Original language	English
Pages (from-to)	159-160
Number of pages	2
Journal	Lung Cancer
Volume	63
Issue number	1
DOIs	https://doi.org/10.1016/j.lungcan.2008.09.007
Publication status	Published - Jan 2009

Keywords

EGFR
K-RAS
Lung
MUC5AC
Mucoepidermoid carcinoma

ASJC Scopus subject areas

Oncology
Pulmonary and Respiratory Medicine
Cancer Research

Access to Document

10.1016/j.lungcan.2008.09.007

Fingerprint Dive into the research topics of 'Mucoepidermoid carcinoma of the lung, response to EGFR inhibitors, EGFR and K-RAS mutations, and differential diagnosis'. Together they form a unique fingerprint.

Cite this

@article{3d483e5349224475b175dea6af05c5ff,

title = "Mucoepidermoid carcinoma of the lung, response to EGFR inhibitors, EGFR and K-RAS mutations, and differential diagnosis",

abstract = "Mucoepidermoid carcinoma (MEC) of the lung needs to be carefully distinguished from other lung tumors with similar features, particularly from adenosquamous carcinoma, this latter tumor frequently showing EGFR mutations. In contrast with the data reported by Han et al in the last July issue of Lung Cancer, neither EGFR nor K-RAS mutations were observed in MEC from caucasian patients.",

keywords = "EGFR, K-RAS, Lung, MUC5AC, Mucoepidermoid carcinoma",

author = "Giulio Rossi and Giuliana Sartori and Alberto Cavazza and Stefano Tamberi",

year = "2009",

month = jan,

doi = "10.1016/j.lungcan.2008.09.007",

language = "English",

volume = "63",

pages = "159--160",

journal = "Lung Cancer",

issn = "0169-5002",

publisher = "Elsevier Ireland Ltd",

number = "1",

}

TY - JOUR

T1 - Mucoepidermoid carcinoma of the lung, response to EGFR inhibitors, EGFR and K-RAS mutations, and differential diagnosis

AU - Rossi, Giulio

AU - Sartori, Giuliana

AU - Cavazza, Alberto

AU - Tamberi, Stefano

PY - 2009/1

Y1 - 2009/1

N2 - Mucoepidermoid carcinoma (MEC) of the lung needs to be carefully distinguished from other lung tumors with similar features, particularly from adenosquamous carcinoma, this latter tumor frequently showing EGFR mutations. In contrast with the data reported by Han et al in the last July issue of Lung Cancer, neither EGFR nor K-RAS mutations were observed in MEC from caucasian patients.

AB - Mucoepidermoid carcinoma (MEC) of the lung needs to be carefully distinguished from other lung tumors with similar features, particularly from adenosquamous carcinoma, this latter tumor frequently showing EGFR mutations. In contrast with the data reported by Han et al in the last July issue of Lung Cancer, neither EGFR nor K-RAS mutations were observed in MEC from caucasian patients.

KW - EGFR

KW - K-RAS

KW - Lung

KW - MUC5AC

KW - Mucoepidermoid carcinoma

UR - http://www.scopus.com/inward/record.url?scp=57649088341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57649088341&partnerID=8YFLogxK

U2 - 10.1016/j.lungcan.2008.09.007

DO - 10.1016/j.lungcan.2008.09.007

M3 - Article

C2 - 18992960

AN - SCOPUS:57649088341

VL - 63

SP - 159

EP - 160

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

IS - 1

ER -